Original Article
Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study
Yizhe Wu, Jiasheng Yin, Jiahui Chen, Zhifeng Yao, Juying Qian, Li Shen, Lei Ge, Junbo Ge, on behalf of the XINSORB first-in-human study